Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Muus, P.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(16)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(12)
+
-
Creation Date
2014
(3)
+
-
2010
(2)
+
-
2011
(2)
+
-
2013
(2)
+
-
2020
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(16)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(16)
+
-
Topic
Acute myeloid leukemia
(2)
+
-
Author
Muus, P.
(16)
+
-
Amadori, S.
(14)
+
-
Suciu, S.
(14)
+
-
Willemze, R.
(14)
+
-
Marie, J.P.
(13)
+
-
Witte, T. de
(13)
+
-
Halkes, C.J.M.
(9)
+
-
Vignetti, M.
(8)
+
-
Meloni, G.
(7)
+
-
Baron, F.
(6)
+
-
Meert, L.
(6)
+
-
Thomas, X.
(6)
+
-
Fazi, P.
(5)
+
-
Lefrere, F.
(5)
+
-
Selleslag, D.
(5)
+
-
Specchia, G.
(5)
+
-
Venditti, A.
(5)
+
-
Berneman, Z.
(4)
+
-
Bron, D.
(4)
+
-
Guimaraes, J.E.
(4)
+
-
Hagemeijer, A.
(4)
+
-
Jansen, J.H.
(4)
+
-
Karrasch, M.
(4)
+
-
Labar, B.
(4)
+
-
Fabbiano, F.
(3)
+
-
Fillet, G.
(3)
+
-
Magro, D.
(3)
+
-
Mancini, M.
(3)
+
-
Mistrik, M.
(3)
+
-
Sborgia, M.
(3)
+
-
Sica, S.
(3)
+
-
Stevens-Kroef, M.
(3)
+
-
Vrhovac, R.
(3)
+
-
Beksac, M.
(2)
+
-
Bourhis, J.H.
(2)
+
-
Camera, A.
(2)
+
-
Cannella, L.
(2)
+
-
Cantore, N.
(2)
+
-
Cilloni, D.
(2)
+
-
Efficace, F.
(2)
+
-
Halkes, S.J.M.
(2)
+
-
Kicinski, M.
(2)
+
-
Mandelli, F.
(2)
+
-
Marijt, E.W.A.
(2)
+
-
Melillo, L.
(2)
+
-
Nobile, F.
(2)
+
-
Sala, E. la
(2)
+
-
Trisolini, S.
(2)
+
-
Wittnebel, S.
(2)
+
-
Show more
Language
en
(16)
+
-
Search results
(1 - 16 of 16)
show grid
show list
save search
Eltrombopag added to immunosuppression in severe aplastic anemia
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukemia
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase 1/11 results of the EORTC
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): p
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EO
Clofarabine in Combination with a Standard Remission Induction Regimen (AraC and idarubicin) in Patients with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Phase I Results of An Ongoing
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
